Question 1

What is LOPJLB’s current signal on CNCR?

Accepted Answer

LOPJLB’s latest quantitative signal on Loncar Cancer Immunotherapy ETF (CNCR) is SELL in a RECOVERY regime. Signals are updated daily.

Question 2

What market regime is CNCR in?

Accepted Answer

Loncar Cancer Immunotherapy ETF (CNCR) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Question 3

What does Loncar Cancer Immunotherapy ETF (CNCR) do?

Accepted Answer

This exchange-traded fund tracks an index primarily consisting of common stock from roughly 30 pharmaceutical or biotechnology companies. These firms are handpicked by the index provider due to their strong emphasis on creating innovative drugs that harness the human body's natural immune defenses to combat cancer. The fund's advisor aims to allocate all, or nearly all, of its capital into the …

Question 4

Where is Loncar Cancer Immunotherapy ETF based / listed?

Accepted Answer

Loncar Cancer Immunotherapy ETF is based in US, listed on NASDAQ.

Loncar Cancer Immunotherapy ETF (CNCR)

Key stats

Prediction markets

Company news